Search Results

You are looking at 101 - 110 of 543 items for :

  • Refine by Access: All x
Clear All
Full access

HSR20-106: Quantifying Patient Preferences for Attributes Associated With First-Line Treatment of Metastatic Non-Small Cell Lung Cancer

Brian Seal, Candice Yong, M. Janelle Cambron-Mellott, Oliver Will, Martine C. Maculaitis, Kelly Clapp, Emily Mulvihill, Ion Cotarla, and Ranee Mehra

%, and all G neuropathy from 5% to 39%, if OS increased by 17, 4, and 2 months, respectively. In addition, pts would require an increase in OS of 1 month to accept an increase in G3/4 fatigue from 1% to 12% or all G pneumonitis from <1% to 8%. Preferences

Full access

Communicating About Chemotherapy-Induced Nausea and Vomiting: A Comparison of Patient and Provider Perspectives

John M. Salsman, Steven M. Grunberg, Jennifer L. Beaumont, Miriam Rogers, Diane Paul, Marla L. Clayman, and David Cella

, available online, in this article, at www.JNCCN.org ) Nausea and Vomiting Management Barriers Questionnaire (NVMBQ) were developed using the Fatigue Management Barriers Questionnaire (FMBQ) 16 as a template. Patient-related barriers to communicating about

Full access

Role of Adjuvant and Posttreatment Exercise Programs in Breast Health

Jennifer A. Ligibel

diagnosis have lower rates of recurrence and death compared with sedentary individuals. A growing number of exercise intervention studies show that increased physical activity after diagnosis leads to improvements in quality of life, fatigue, and body image

Full access

Urothelial Carcinoma of the Bladder and the Rise of Immunotherapy

David D. Chism

-related AEs (TRAEs) included fatigue, pneumonitis, rash, and dyspnea. Among the 119 cisplatin-ineligible patients in cohort 1 who received atezolizumab in the first-line setting, there was an ORR of 23% (95% CI, 16–31) and a CR of 9%, with durable responses

Full access

Distress Screening and the Integration of Psychosocial Care Into Routine Oncologic Care

Jimmie C. Holland

-report was considered totally invalid,” explained Dr. Holland. To begin to measure subjective symptoms, validated, quantitative tools were developed in the 1970s and 1980s. Scales focused on items such as health-related quality of life, pain, fatigue

Full access

Targeting Angiogenesis in Advanced Non-Small Cell Lung Cancer

Philip E. Lammers and Leora Horn

show superiority. The toxicities differed between arms; more grade 3/4 thrombocytopenia (23.3% vs 5.6%), anemia (14.5% vs 2.7%), and fatigue (10.9% vs 5.0%) were seen in the pemetrexed group, whereas more grade 3/4 neutropenia (40.6% vs 25.8%), febrile

Full access

The NCCN 2023 Annual Conference

and suggested approaches that can improve inclusion and equity in oncology. In another plenary session focused on sleep disorders, fatigue, and cognitive function in cancer survivors (synopsis available at JNCCN.org ) speakers again noted the need

Full access

New Meets Old: A Case Study and Review of Novel Therapeutics for the Treatment of CLL in Older Patients

Neel K. Gupta and Charalambos Andreadis

performed. He was asymptomatic, without palpable adenopathy or organomegaly, and was monitored expectantly during the next 5 years, remaining free of symptoms or hematologic abnormalities. By August 2009 he developed mild fatigue, cervical lymphadenopathy

Full access

Prevalence of Insomnia in an Oncology Patient Population: An Irish Tertiary Referral Center Experience

Emily C. Harrold, Ahmad F. Idris, Niamh M. Keegan, Lynda Corrigan, Min Yuen Teo, Martin O’Donnell, Sean Tee Lim, Eimear Duff, Dearbhaile M. O’Donnell, M. John Kennedy, Sue Sukor, Cliona Grant, David G. Gallagher, Sonya Collier, Tara Kingston, Ann Marie O’Dwyer, and Sinead Cuffe

trajectory, with an impact on multiple functional domains and a deleterious effect on overall quality of life. 48 Improving sleep outcomes is significantly related to improvements in quality of life and reduced daytime fatigue. 49 Data also suggest an

Full access

Systematic Review of Randomized Controlled Trials of Exercise Interventions Using Digital Activity Trackers in Patients With Cancer

Kerry Schaffer, Narmadha Panneerselvam, Kah Poh Loh, Rachel Herrmann, Ian R. Kleckner, Richard Francis Dunne, Po-Ju Lin, Charles E. Heckler, Nicholas Gerbino, Lauren B. Bruckner, Eugene Storozynsky, Bonnie Ky, Andrea Baran, Supriya Gupta Mohile, Karen Michelle Mustian, and Chunkit Fung

intensity as part of routine cancer care. Poor adherence to exercise interventions is a major barrier to achieving the optimal benefits of exercise. 13 – 16 The presence of symptoms related to cancer and its treatments, including fatigue, depression